AW
AMPH icon

Avion Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History

Avion Wealth’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
24
-60
-71% -$1.47K ﹤0.01% 1217
2025
Q4 		$2K Sell
84
-40
-32% -$1.03K ﹤0.01% 838
2025
Q3 		$3K Buy
124
+64
+107% +$1.65K ﹤0.01% 720
2025
Q2 		$1K Buy
+60
New +$1.49K ﹤0.01% 896

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Avion Wealth's AMPH Position: Q1 2026 in Review

Avion Wealth reduced its Amphastar Pharmaceuticals (AMPH) stake by 71% in Q1 2026, selling an estimated $1.47K and leaving 24 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1217.

Avion Wealth first reported a position in AMPH in Q2 2025 and has held it in 4 quarters since. The position peaked at $3K in Q3 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Avion Wealth held 24 shares of Amphastar Pharmaceuticals worth $0 as of Q1 2026.
  • Avion Wealth sold 60 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $1.47K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #1217 holding.
  • Avion Wealth first reported a position in Amphastar Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Avion Wealth's Amphastar Pharmaceuticals position peaked at $3K in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.